Perez Edith A. 4
4 · Bolt Biotherapeutics, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Perez Edith A.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2021-06-04$16.65/sh+917$15,268→ 917 total - Exercise/Conversion
Common Stock
2021-12-22$2.80/sh+35,714$99,999→ 37,042 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-22−35,714→ 189,286 totalExercise: $2.80Exp: 2030-07-28→ Common Stock (35,714 underlying) - Purchase
Common Stock
2021-12-06$4.64/sh+411$1,907→ 1,328 total
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c).
- [F2]1/4th of the shares subject to the option shall vest on the one year anniversary of April 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a service provider through each such date.